Several antibiotics, other drugs may get cheaper
Medicines and devices listed in the NLEM must be sold at the prices set by National Pharmaceuticals Pricing Authority (NPPA), while those in the non scheduled list are allowed a maximum annual price increase of 10%. The revision of the NLEM aims to ensure that antibiotics are available when needed, and that the right antibiotics are prescribed for the right infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 13, 2022 Category: Pharmaceuticals Source Type: news

CIC issues show-cause notice to CDSCO for denial of info on WHO's suspension on Covaxin procurement
Under Section 20 of the RTI Act, if CIC is convinced that information denial was unjustified and arising out of malafide intention, it may impose a penalty of Rs 250 from the day the information became due to the day it was furnished subject to a maximum limit of Rs 25,000 which would be deducted from the salary of the CPIO. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 13, 2022 Category: Pharmaceuticals Source Type: news

Anesthesia drug Lignocaine reduces risk of metastasis after breast cancer surgery
The lignocaine treatment costs just Rs 100 per patient, who need just one injection, around the tumor just prior to surgery. The injection requires no additional expertise. The study was carried out in 1600 women undergoing breast cancer surgery.Lignocaine was known to have inhibitory effects on cancer cell division, movement and other anti-cancer properties. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2022 Category: Pharmaceuticals Source Type: news

Tata Memorial Centre, doctors from 11 institutes develop low-cost clinical intervention for cancer treatment
"The research has suggested there is a window of opportunity just prior to, during, and immediately after surgical removal of primary cancer when anti-cancer interventions could reduce the risk of development of disseminated stage-four metastatic cancer later in the lifespan of the patient," the hospital said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2022 Category: Pharmaceuticals Source Type: news

Bharat Biotech seeks DCGI nod for phase-3 study of intranasal Covid vaccine in 5-18 age group
iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candidate was evaluated in phase 1, 2 and 3 clinical trials with successful results, a release from the vaccine-maker said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 11, 2022 Category: Pharmaceuticals Source Type: news

Pharma association gives clean chit to Dolo-maker
The IPA has submitted a report to the Department of Pharmaceuticals (DoP) and National Pharmaceutical Pricing Authority (NPPA) stating that the company was "following the processes as per the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) guidelines" and they did not find any wrong doing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 10, 2022 Category: Pharmaceuticals Source Type: news

IOL to diversify its API and specialty chemicals portfolios to boost sales
The Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integrated manufacturing the key starting material Isobutylbenzene needed for making the drug. Ibuprofen, an age-old drug, is used in the treatment of pain. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news

Lupin gets US FDA approval for generic used to cleanse colon
US FDA's approval is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces, Lupin said in a stock exchange filing. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution had estimated annual sales of USD 202 million in the U.S., it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news

Zydus bags rights to market MonoFerric injection in India, Nepal from Pharmacosmos A/S of Denmark
Zydus Lifesciences Ltd on Friday said it has acquired rights to market MonoFerric (iron isomaltoside) injection, used to treat iron deficiency in adult patients, in India and Nepal from Denmark-based Pharmacosmos A/S. The financial details of the transaction have not been disclosed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news

Zydus buys rights from Pharmacosmos to sell drug to treat anemia in India, Nepal
MonoFerric injection is a rapid, single dose intravenous therapy used for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used. MonoFerric is available in over 30 countries including US and Europe and over 28 million doses have been administered since launch. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic Revlimid in US market
"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bringing a more affordable generic version to market creates greater patient access for this important drug," Marc Kikuchi, CEO, North America Generics, Dr. Reddy's said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 8, 2022 Category: Pharmaceuticals Source Type: news

Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet study
The data were gathered from a panel of 9,000 stockists who store products from approximately 5,000 pharmaceutical companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2022 Category: Pharmaceuticals Source Type: news

Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines
The biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml) and Xgeva (denosumab 70 mg/ml) for treating osteoporosis, Simponi (golimumab) for treating rheumatoid arthritis, and Eylea (aflibercept) against wet-age macular degeneration as well as two undisclosed proposed biosimilars for immunology and oncology. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2022 Category: Pharmaceuticals Source Type: news

Merck will look to hire more talent, improve R & D efficiency: Danny Bar-Zohar, global head of R & D
The company is also looking at potential collaborations with Indian biotech firms and contract research organisations for development, manufacturing and co-commercialisation opportunities. Merck last week opened its India R&D Excellence Centre. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2022 Category: Pharmaceuticals Source Type: news

US-based Allurion Technologies launches its weight loss gastric balloon in India
The Allurion Program costs Rs 3 lakh in India. People with body mass index (BMI) of 27 and above are eligible for the treatment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2022 Category: Pharmaceuticals Source Type: news